You searched for Cancer.
Page 4 of 443 results
Phase 1 Study of ABI-009 (nab-rapamycin) in Pediatric Patients with Recurrent or Refractory Solid Tumors, including CNS Tumors as a Single Agent and in Combination with Temozolomide and Irinotecan
Clinical Trial Protocol # ADVL1514 | Adolescents and Young Adults, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Phase 1/2 Study of VX15/2503 (IND# 136181) in Children, Adolescents, or Young Adults with Recurrent or Relapsed Solid Tumors
Clinical Trial Protocol # ADVL1614 | Adolescents and Young Adults, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Phase II open-label global study to evaluate the effect of dabrafenib in combination with trametinib in children and adolescent patients with BRAF V600 mutation positive relapsed or refractory High Grade Glioma (HGG)
Clinical Trial Protocol # CDRB436G2201 | Adolescents and Young Adults, Brain Tumor/Central Nervous System/Neuro-Oncology, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Yun, Christine S., NP
Christine Yun is a nurse practitioner who specializes in oncology. She provides care for pediatric cancer patients at CHOC in Orange County.
No Place Like CHOC: Jenee Areeckal
There's no place like CHOC. Jenee Areeckal, Oncology Social Worker at CHOC Hospital, tells us about the importance of treating the whole family.
Adolescent and Young Adult (AYA) Treatment Program
CHOC has one of the only cancer programs in the country just for teens and young adults, meaning we “get” what they need—medically, emotionally and beyond.
Side Effects of Chemotherapy and Radiation in Children
While chemotherapy and radiation are both treatments used to treat cancer, they differ in the way they work.
Parent Advice Line
To use PAL, simply call (714) 912-8927, enter the four-digit topic numbers listed on this web page, or stay on the line for a complete listing of topics.
Sender, Leonard S. MD
Dr. Sender is a pediatric oncologist who treats children and teens at CHOC.
Lin, Carol MD
Dr. Lin is a CHOC Specialist in pediatric hematology/oncology and is board certified in pediatrics.
Oncology Clinical Trial: Study of Kidney Tumors in Younger Patients
Clinical Trial Protocol # AREN03B2 | Biology/Genomics, Registry | Contact (714) 509-8646
Kirov, Ivan I. MD
Dr. Kirov serves as CHOC Specialists director of the lymphoma program and recurrent/refractory cancer program.
Huynh, Van T. MD
Dr. Huynh is a pediatric oncologist who specializes in acute leukemia. She is board certified in both general pediatrics and pediatric hematology/oncology.
Navalkele, Pournima D. MD
Dr. Pournima Navalkele is a board certified pediatric oncologist at CHOC Hospital in Orange County.
Rubin, Elyssa MD
Dr. Rubin serves as the director of the Bone and Soft Tissue Tumor Program at CHOC Hospital and is an oncologist with CHOC Specialists.
Mucci, Grace PhD
Dr. Grace Mucci, PhD, is a board-certified pediatric neuropsychologist and coordinator of the Neuropsychology Program at CHOC Hospital.
Morales, Sonia MD
Dr. Sonia Morales is a board certified pediatric oncologist at CHOC Hospital in Orange County.
Neudorf, Steven M. MD
Dr. Neudorf is a CHOC Specialist in pediatric oncology at CHOC Hospital.
Horvath, Agnes MD
Dr. Horvath is a pediatric hematology/oncology with CHOC Specialists and is board certified in pediatrics, pediatric hematology/oncology.
ADVL1615, A Phase 1 Study of Pevonedistat (MLN4924, IND# 136078), a NEDD8 Activating Enzyme (NAE) Inhibitor, in Combination with Temozolomide and Irinotecan in Pediatric Patients with Recurrent or Refractory Solid Tumors
Clinical Trial Protocol # ADVL1615 | Adolescents and Young Adults, Brain Tumor/Central Nervous System/Neuro-Oncology, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Histiocytosis: Dr. Torno
Dr. Lilibeth Torno, Clinical Director of Hyundai Cancer Institute at CHOC, describes symptoms and treatment of histiocytosis.
Clinical Trials: Dr. Sender
Dr. Leonard Sender, Medical Director, Hyundai Cancer Institute at CHOC, describes for us the three phases of clinical trials.
Oncology Clinical Trial: Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Clinical Trial Protocol # AALL1331 | Leukemia/Lymphoma, Recurrent/Refractory Cancer | Contact (714) 509-8646
Oncology Clinical Trial: Pazopanib Paediatric Phase II Trial Children’s Oncology Group (COG) in Solid Tumors
Clinical Trial Protocol # ADVL1322 | Adolescents and Young Adults, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Miller, Tara L. NP
Tara Miller is a certified Nurse Practitioner for oncology and provides care for pediatric cancer patients at CHOC Hospital in Orange.
